Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $29,684 | 1,217 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,349 | 68 | $0 (2024) |
| Amgen Inc. | $2,221 | 81 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,887 | 56 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,883 | 55 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $1,642 | 59 | $0 (2024) |
| ABBVIE INC. | $1,552 | 94 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,497 | 49 | $0 (2023) |
| Abbott Laboratories | $1,420 | 42 | $0 (2024) |
| Lundbeck LLC | $1,373 | 58 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,197 | 115 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,367 | 293 | AstraZeneca Pharmaceuticals LP ($901.04) |
| 2023 | $8,090 | 294 | Abbott Laboratories ($1,080) |
| 2022 | $6,551 | 292 | Amgen Inc. ($540.77) |
| 2021 | $7,676 | 338 | Janssen Pharmaceuticals, Inc ($998.38) |
All Payment Transactions
1,217 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $24.30 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 12/26/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: PAIN | ||||||
| 12/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Insomnia | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $13.52 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 12/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.30 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $33.61 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $19.71 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Oncology | ||||||
| 11/14/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/12/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: HORMONE REPLACEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 416 | 677 | $75,515 | $35,555 |
| 2022 | 7 | 353 | 567 | $54,265 | $27,294 |
| 2021 | 7 | 329 | 484 | $45,095 | $23,264 |
| 2020 | 7 | 299 | 450 | $41,780 | $18,620 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 271 | $29,435 | $13,430 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 81 | $10,935 | $6,295 | 57.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 47 | 47 | $9,165 | $5,245 | 57.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 32 | 61 | $8,235 | $5,118 | 62.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 35 | 64 | $8,000 | $3,233 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $4,000 | $1,377 | 34.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 74 | 75 | $4,875 | $660.00 | 13.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 51 | 58 | $870.00 | $197.78 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 217 | $20,615 | $11,239 | 54.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 52 | 134 | $13,360 | $7,158 | 53.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $5,850 | $3,431 | 58.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $5,600 | $2,379 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 26 | $3,510 | $2,307 | 65.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 66 | 67 | $4,355 | $556.98 | 12.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 62 | 65 | $975.00 | $222.77 | 22.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 179 | $17,005 | $9,147 | 53.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 62 | 62 | $12,090 | $7,270 | 60.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 31 | 83 | $7,885 | $4,549 | 57.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $2,200 | $1,176 | 53.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 64 | 64 | $4,160 | $527.50 | 12.7% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2021 | 24 | 24 | $840.00 | $382.08 | 45.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 59 | 61 | $915.00 | $212.28 | 23.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 72 | 188 | $17,860 | $7,908 | 44.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 52 | 52 | $10,140 | $5,347 | 52.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 44 | 75 | $7,125 | $3,621 | 50.8% |
About Mark Clarke, NPP32626
Mark Clarke, NPP32626 is a Family healthcare provider based in Smithfield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790850584.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Clarke, NPP32626 has received a total of $29,684 in payments from pharmaceutical and medical device companies, with $7,367 received in 2024. These payments were reported across 1,217 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($29,684).
As a Medicare-enrolled provider, Clarke has provided services to 1,397 Medicare beneficiaries, totaling 2,178 services with total Medicare billing of $104,733. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Smithfield, RI
- Active Since 11/21/2006
- Last Updated 05/26/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1790850584
Products in Payments
- XARELTO (Drug) $1,918
- JARDIANCE (Drug) $1,505
- NURTEC ODT (Drug) $1,263
- HETLIOZ (Drug) $1,258
- VRAYLAR (Drug) $1,239
- TRINTELLIX (Drug) $1,197
- FARXIGA (Drug) $1,168
- FREESTYLE LIBRE 3 (Device) $1,133
- VYEPTI (Biological) $1,087
- Otezla (Drug) $1,075
- TRELEGY ELLIPTA (Drug) $941.91
- XIFAXAN (Drug) $729.72
- BREZTRI (Drug) $717.87
- TOUJEO (Biological) $667.28
- Aimovig (Biological) $662.46
- SOLIQUA 100/33 (Biological) $564.54
- REXULTI (Drug) $496.53
- Ozempic (Drug) $483.37
- AREXVY (Drug) $481.85
- Repatha (Biological) $410.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Smithfield
Nichole Wilson, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $9,329
Ms. Ashley Liese, Np-C, NP-C
Family — Payments: $8,480
Abbey Barkley Davis, Np, NP
Family — Payments: $7,026
Leslie Ann Dupree, Fnp, FNP
Family — Payments: $3,979
Ms. Christina Peacock, Fnp, FNP
Family — Payments: $3,578
Arnold Mclendon, Fnp, FNP
Family — Payments: $2,023